Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.

While it is clear that men with lower urinary ... inability to differentiate between symptoms attributable to detrusor overactivity (DO) and those caused by bladder-outlet obstruction (BOO ...

According to doctors, most men may be less likely to report symptoms due to embarrassment. Also, a few age-related prostate issues result in overactive bladder symptoms for men – who think it is ...

Lower urinary tract symptoms and overactive bladder are ... and a combination of both, in men with overactive bladder and benign prostatic hyperplasia. With regard to efficacy, 80% of patients ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur. Urol. 55 , 472–479 (2009).

Managing your OAB may be as simple as knowing which foods trigger symptoms, or resting during an eventful day. Coping with overactive bladder -- away or at home -- is in your hands. Between ...

We have several treatment options for overactive bladder. The medications we use can have harsh side effects, so we prefer to start with a more natural and gentle approach. The first thing we ask ...

Conclusions: Tolterodine 2mg twice daily is effective against all the troublesome symptoms of overactive bladder and these effects are meaningful to patients. Tolterodine was well tolerated.